首页> 外文期刊>Journal of Photochemistry and Photobiology, A. Chemistry >Single- and two-photon absorption induced photocleavage of dimeric coumarin linkers: Therapeutic versus passive photocleavage in ophthalmologic applications
【24h】

Single- and two-photon absorption induced photocleavage of dimeric coumarin linkers: Therapeutic versus passive photocleavage in ophthalmologic applications

机译:二聚体香豆素接头的单光子吸收和双光子吸收诱导的光裂解:眼科应用中的治疗性与被动性光裂解

获取原文
获取原文并翻译 | 示例
           

摘要

Phototriggered chemical reactions are elegant and spatially selective. However, in application a general problem is that aside of the desired changes, e.g. induced by laser, undesired changes may occur, e.g. induced by daylight or sunlight. One such example which we are studying here is the phototriggered release of drugs from materials suitable for polymeric intraocular lenses (IOL). Through such an IOL sunlight needs to pass for several years without affecting the drug loading, but at the therapeutically required moment the drug release shall be triggered also by light. We studied this using a novel coumarin dimer (7,7′-[3-(tert-butyldimethylsilyloxy)propoxy]-dicoumarin) synthesized from the monomer in a photochemical [2π + 2π] cycloaddition reaction. The cleavage of the obtained photodimer by single-photon (SPA) and two-photon absorption (TPA) excitation was investigated in acetonitrile solution and in polymethylmethacrylate in order to exclude major matrix entrapment effects. The cleavage quantum yields and TPA cross-section were determined to be Φ ≈ 0.13 and δTPA ≈ 2.7 GM, respectively. It was found that 10% undesired drug release would require more than 16 years of continuous exposure to sunlight. Release of 90% of drug under therapeutic conditions would be completed within seconds. This shows that photochemically triggered drug release is capable to become a powerful tool for drug delivery in ophthalmology.
机译:光触发的化学反应优雅且在空间上具有选择性。但是,在应用中,一个普遍的问题是除了期望的改变之外,例如,改变了它。激光引起的意外变化可能发生,例如由日光或阳光诱导。我们在这里研究的一个这样的例子是从适用于聚合物人工晶状体(IOL)的材料中光触发释放药物。通过这样的IOL,阳光需要经过数年而不影响药物加载,但是在治疗需要的时刻,药物释放也应由光触发。我们使用一种在光化学[2π+2π]环加成反应中从单体合成的新型香豆素二聚体(7,7'-[3-(叔丁基二甲基甲硅烷基氧基)丙氧基]-双香豆素)进行了研究。在乙腈溶液和聚甲基丙烯酸甲酯中研究了通过单光子(SPA)和双光子吸收(TPA)激发对获得的光二聚体的裂解,以排除主要的基质截留效应。分裂量子产率和TPA横截面分别确定为Φ≈0.13和δTPA≈2.7GM。已经发现,不希望的药物释放10%将需要连续暴露超过16年的阳光。在治疗条件下90%的药物释放将在几秒钟内完成。这表明光化学触发的药物释放能够成为眼科药物输送的强大工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号